By South SFV Today |
Mar 16, 2024
Stanford researchers have unveiled a promising new compound, ML2006a4, designed at the atomic level, which could serve as a potent anti-coronavirus drug in the fight against evolving COVID-19 variants. The compound, detailed in a paper published in Science Translational Medicine, has shown superior efficacy in preclinical experiments compared to the current oral drug Paxlovid.Senior author of the study, Michael Lin, emphasized the need for alternative drugs that are more resilient to mutations, stating, "As new waves of coronavirus keep crashing down, we need to have...